Scientists multiply immune cells from HIV-infected patients and then place them back in the body to fight the virus
New therapy for HIV passed Phase 1 clinical trial - science news in short - HIV

A new therapy for HIV is now tested in humans and it successfully passed the phase I clinical trial. The therapy involves collecting T cells (immune cells) from a patient, multiplying them in the laboratory and then giving them back to the patient to help the body fight disease. Basically, the body’s immune system is helped and “re-educated” to better fight HIV viruses. The primary goal of the study was to show that the therapy is safe and the results are encouraging. The therapy is still to be further tested in future clinical trials.

Read the full story: ScienceDaily
Scientific publication: Molecular Therapy